Procognia (Group)

https://www.procognia.com

Procognia (Israel) Ltd. is a leading biotechnology company in the fields of Glycobiology and Glycoanalysis, with an exclusive range of proprietary technologies and applications covering four key platforms: analytics, diagnostics, therapeutic antibodies and stem cells. As a publicly traded company on the Tel Aviv Stock Exchange (TASE: PRCG), Procognia established itself as a dominant player in glycomics with the development of an innovative high throughput lectin array based glycoanalysis platform technology, the GlycoScopeTM. Based on its expertise, the company is currently focusing on the development of breakthrough in-vitro and in-vivo cancer diagnostics, targeted cancer therapy technologies and stem cell applications. *

	Start	2002-04-01 renamed
	Industry	BIOTECH
	Industry 2	GlycoScope™ microarray platform

	Region	Maidenhead, Berkshire
	Country	United Kingdom (GB)
	Street	Unit 4, The Switchback, Gardner Road
	City	SL6 7RJ Maidenhead, Berkshire
	Tel	+44-1628-513500
		Address record changed: 2020-12-02

Basic data	Employees	n. a.

		* Document for »About Section«:

		Record changed: 2023-07-10

Picture Berlin Partner Voices Robinson Data for Precision Medicine 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)